about
Antepartum Antibiotic Treatment Increases Offspring Susceptibility to Experimental Colitis: A Role of the Gut Microbiota.Stability of Reference Genes for Messenger RNA Quantification by Real-Time PCR in Mouse Dextran Sodium Sulfate Experimental Colitis.Human Catestatin Alters Gut Microbiota Composition in Mice.Immunomodulatory effect of ghrelin in the intestinal mucosa.Appropriateness of reference genes for normalizing messenger RNA in mouse 2,4-dinitrobenzene sulfonic acid (DNBS)-induced colitis using quantitative real time PCR.Reactivation of Intestinal Inflammation Is Suppressed by Catestatin in a Murine Model of Colitis via M1 Macrophages and Not the Gut Microbiota.Expression of Hsp70, Igf1, and Three Oxidative Stress Biomarkers in Response to Handling and Salt Treatment at Different Water Temperatures in Yellow Perch, Perca flavescens.Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages.Chromofungin (CHR: CHGA47-66) is downregulated in persons with active ulcerative colitis and suppresses pro-inflammatory macrophage function through the inhibition of NF-κB signaling.Chromogranin-A Regulates Macrophage Function and the Apoptotic Pathway in Murine DSS colitis.Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration.Retinoic acid-mediated anti-inflammatory responses in equine immune cells stimulated by LPS and allogeneic mesenchymal stem cells.Mixed Bacillus Species Enhance the Innate Immune Response and Stress Tolerance in Yellow Perch Subjected to Hypoxia and Air-Exposure Stress.Chromogranin-A and its derived peptides and their pharmacological effects during intestinal inflammation.Mucosal immunity and gut microbiota in dogs with chronic enteropathySemaphorin-3E attenuates intestinal inflammation through the regulation of the communication between splenic CD11C+ and CD4+ CD25- T-cellsCatestatin Regulates Epithelial Cell Dynamics to Improve Intestinal InflammationSemaphorin 3E regulates apoptosis in the intestinal epithelium during the development of colitis
P50
Q35852097-6E929227-9737-462C-996A-A5003A3CAF9DQ36951332-93C41958-6876-4F14-B6FA-AEFDD3EAED4FQ37588595-5EEAF7CB-9F4E-48A1-B974-345D4D9DB8D4Q38616729-287551C8-F6F3-4DD5-87D4-D2F01C31F44DQ38967872-3BE5AA73-E1E9-479D-BCF5-AD4B2F9753B0Q41487887-E54B91EC-2DE9-4D7A-B8A5-BC439A0DFD97Q41684525-E2304BA3-075E-46C9-A8B3-B6BC50068327Q41688556-1CBF61F9-11AB-4985-8D6A-6A9692FED553Q47818401-94F5F618-AB77-4CFC-9598-4F92949FA46DQ49604394-05DE9BCB-DB56-4808-AB6D-8B896892E853Q51738230-E86916DA-B1D2-4F24-B975-E9BE917A575FQ52770754-4466F0A5-06C7-43E3-9578-EDEDBEE56F56Q53686838-4A538A60-F3AE-4937-99ED-89B24E6A1FB8Q53821960-DCC4DF7D-1040-435C-ABD4-36F7243A243CQ90026833-80A22F95-F7C1-4ADE-850B-A14CCFF8F138Q91423551-8093CEE5-87D4-4000-9571-AF96AF704E13Q91631423-4592B295-8D2F-4CCA-91BA-BDF4295F2C01Q92563824-720EE514-F273-4A49-B070-A7DD36201340
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nour Eissa
@ast
Nour Eissa
@en
Nour Eissa
@es
Nour Eissa
@nl
Nour Eissa
@sl
type
label
Nour Eissa
@ast
Nour Eissa
@en
Nour Eissa
@es
Nour Eissa
@nl
Nour Eissa
@sl
prefLabel
Nour Eissa
@ast
Nour Eissa
@en
Nour Eissa
@es
Nour Eissa
@nl
Nour Eissa
@sl
P1053
E-1464-2013
P106
P1153
55797358500
57197572958
P1960
MFDdEHUAAAAJ
P2038
Nour_Eissa
P2798
P31
P3829
P3835
nour-eissa
P496
0000-0002-3484-6720
P569
2000-01-01T00:00:00Z